Does Cytomegalovirus Serology Impact Outcome After Pediatric Heart Transplantation?

Journal of Heart and Lung Transplantation

Volumn 28, Issue 12, 2009, Pages 1299-1305

  Mahle, William T ^a   Fourshee, Margaret T ^b   Naftel, David M ^b   Alejos, Juan C ^c   Caldwell, Randall L ^d   Uzark, Karen ^e   Berg, Alexandria ^a   Kanter, Kirk R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Kentucky   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RILEY CHILDREN S HOSPITAL   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GANCICLOVIR; IMMUNOGLOBULIN; VALGANCICLOVIR;

ADOLESCENT; ADULT; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; FEMALE; GRAFT RECIPIENT; GROUPS BY AGE; HEART TRANSPLANTATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN DONOR; OUTCOME ASSESSMENT; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SCHOOL CHILD; SEROLOGY; TREATMENT DURATION;

ANTIBODIES, VIRAL; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; INCIDENCE; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 70450224669     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.07.011     Document Type: Article

References (21)

1. Sambiase N.V., Higuchi M.L., Nuovo G., et al. CMV and transplant-related coronary atherosclerosis: an immunohistochemical, in situ hybridization, and polymerase chain reaction in situ study. Mod Pathol 13 (2000) 173-179
2. Valantine H.A. Role of CMV in transplant coronary artery disease and survival after heart transplantation. Transplant Infect Dis 1 suppl 1 (1999) 25-30
3. Decoene C., Pol A., Dewilde A., et al. Relationship between CMV and graft rejection after heart transplantation. Transplant Int 9 suppl 1 (1996) S241-S242
4. Hussain T., Burch M., Fenton M.J., et al. Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children. Circulation 115 (2007) 1798-1805
5. Gall S.A. Maternal immunization to protect the mother and neonate. Expert Rev Vaccines 4 (2005) 813-818
6. Pahl E., Naftel D.C., Kuhn M.A., et al. The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study. J Heart Lung Transplant 24 (2005) 645-651
7. Boucek Jr. R.J., Naftel D., Boucek M.M., et al. Induction immunotherapy in pediatric heart transplant recipients: a multicenter study. J Heart Lung Transplant 18 (1999) 460-469
8. Vozarova L., Huckova D., Noskovicova M., et al. The occurrence of symptomatic CMV infections in heart transplant recipients. Bratisl Lek Listy 104 (2003) 317-322
9. Bunde T., Kirchner A., Hoffmeister B., et al. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 201 (2005) 1031-1036
10. Koskinen P., Lemstrom K., Bruning H., et al. Cytomegalovirus infection induces vascular wall inflammation and doubles arteriosclerotic changes in rat cardiac allografts. Transplant Proc 27 (1995) 574-575
11. Simmonds J., Fenton M., Dewar C., et al. Endothelial dysfunction and cytomegalovirus replication in pediatric heart transplantation. Circulation 117 (2008) 2657-2661
12. Fearon W.F., Potena L., Hirohata A., et al. Changes in coronary arterial dimensions early after cardiac transplantation. Transplantation 83 (2007) 700-705
13. Weill D. Role of cytomegalovirus in cardiac allograft vasculopathy. Transplant Infect Dis 3 suppl 2 (2001) 44-48
14. Potena L., Grigioni F., Ortolani P., et al. Relevance of cytomegalovirus infection and coronary-artery remodeling in the first year after heart transplantation: a prospective three-dimensional intravascular ultrasound study. Transplantation 75 (2003) 839-843
15. Hussain T., Burch M., Fenton M.J., et al. Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children. Circulation 115 (2007) 1798-1805
16. Boucek M.M., Aurora P., Edwards L.B., et al. Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric heart transplantation report-2007. J Heart Lung Transplant 26 (2007) 796-807
17. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 26 (2007) 769-781
18. Davies R., Russo M.J., Mital S.R., et al. The influence of CMV status on outcomes following heart transplantation in children-whose status matters?. J Heart Lung Transplant 28 suppl (2009) 2
19. Costanzo M.R., Naftel D.C., Pritzker M.R., et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. J Heart Lung Transplant 17 (1998) 744-753
20. Dayton J.D., Kanter K.R., Vincent R.N., et al. Cost-effectiveness of pediatric heart transplantation. J Heart Lung Transplant 25 (2006) 409-415
21. Gerbase M.W., Dubois D., Rothmeier C., et al. Costs and outcomes of prolonged cytomegalovirus prophylaxis to cover the enhanced immunosuppression phase following lung transplantation. Chest 116 (1999) 1265-1272